101 related articles for article (PubMed ID: 9101041)
1. Effect of sulphur mustard on the expression of urokinase in cultured 3T3 fibroblasts.
Detheux M; Jijakli H; Lison D
Arch Toxicol; 1997; 71(4):243-9. PubMed ID: 9101041
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
Koli K; Keski-Oja J
J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
[TBL] [Abstract][Full Text] [Related]
6. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
8. Molecular determination of laminin-5 degradation: a biomarker for mustard gas exposure diagnosis and its mechanism of action.
Jin X; Ray R; Leng Y; Ray P
Exp Dermatol; 2008 Jan; 17(1):49-56. PubMed ID: 18095945
[TBL] [Abstract][Full Text] [Related]
9. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
[TBL] [Abstract][Full Text] [Related]
10. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
[TBL] [Abstract][Full Text] [Related]
11. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
Ries C; Popp T; Egea V; Kehe K; Jochum M
Toxicology; 2009 Sep; 263(1):26-31. PubMed ID: 18809459
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
17. Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK-14 human keratinocytes in vitro.
Smith CN; Lindsay CD; Upshall DG
Hum Exp Toxicol; 1997 May; 16(5):247-53. PubMed ID: 9192202
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in sulfur mustard treated A549 cell cultures.
Steinritz D; Emmler J; Hintz M; Worek F; Kreppel H; Szinicz L; Kehe K
Life Sci; 2007 May; 80(24-25):2199-201. PubMed ID: 17229443
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
[TBL] [Abstract][Full Text] [Related]
20. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
Vitti G; Hamilton JA
Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
